Published in Am J Pathol on November 01, 2003
Functional analysis of the transcription repressor PLU-1/JARID1B. Mol Cell Biol (2007) 1.57
Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Res (2009) 1.16
Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy. J Biol Inorg Chem (2011) 0.94
Molecular functions of metallothionein and its role in hematological malignancies. J Hematol Oncol (2012) 0.93
Time-series clustering of gene expression in irradiated and bystander fibroblasts: an application of FBPA clustering. BMC Genomics (2011) 0.92
Genome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer. Clin Epigenetics (2015) 0.88
Profiling of zinc-altered gene expression in human prostate normal vs. cancer cells: a time course study. J Nutr Biochem (2008) 0.85
Cytosolic antibody delivery by lipid-sensitive endosomolytic peptide. Nat Chem (2017) 0.82
Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions. J Clin Pathol (2006) 0.79
Metallothionein-I/II Knockout Mice Aggravate Mitochondrial Superoxide Production and Peroxiredoxin 3 Expression in Thyroid after Excessive Iodide Exposure. Oxid Med Cell Longev (2015) 0.78
Quantitative immunogold study of increased expression of metallothionein-I/II in the brain perivascular areas of diabetic scrapie-infected mice. J Mol Histol (2006) 0.76
Differential analysis of CD4+ Th memory clones with identical T-cell receptor (TCR)-alphabeta rearrangement (non-transgenic), but distinct lymphokine phenotype, reveals diverse and novel gene expression. Immunology (2004) 0.76
Propiece IL-1α facilitates the growth of acute T-lymphocytic leukemia cells through the activation of NF-κB and SP1. Oncotarget (2017) 0.75
Screening of hepatocyte proteins binding to complete S protein of hepatitis B virus by yeast-two hybrid system. World J Gastroenterol (2005) 0.75
Molecular portraits of human breast tumours. Nature (2000) 94.14
Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol (1978) 33.47
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol (2000) 29.28
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol (1992) 3.15
Biochemistry of metallothionein. Biochemistry (1988) 2.93
The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res (1997) 2.08
The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures. J Cell Biol (1997) 2.03
Overexpression of metallothionein confers resistance to anticancer drugs. Science (1988) 2.03
Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry (1994) 1.91
MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci U S A (1992) 1.84
RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Clin Cancer Res (2003) 1.67
Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol (2000) 1.56
Detection of stromal invasion in breast cancer: the myoepithelial markers. Adv Anat Pathol (2000) 1.52
Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast. Am J Pathol (1989) 1.46
Human metallothionein genes: structure of the functional locus at 16q13. Genomics (1990) 1.46
Isolation of pure populations of epithelial and myoepithelial cells from the normal human mammary gland using immunomagnetic separation with Dynabeads. Anal Biochem (1995) 1.33
Breast cell invasive potential relates to the myoepithelial phenotype. Int J Cancer (2003) 1.33
Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis (2002) 1.32
Human metallothionein genes are clustered on chromosome 16. Proc Natl Acad Sci U S A (1984) 1.23
Isoform-specific expression of metallothionein mRNA in the developing and adult human kidney. Toxicol Lett (1996) 1.23
Role of thrombin receptor in breast cancer invasiveness. Br J Cancer (1999) 1.22
Cell-type specific and differential regulation of the human metallothionein genes. Correlation with DNA methylation and chromatin structure. J Biol Chem (1990) 1.17
Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J Pathol (2003) 1.16
A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness. J Natl Cancer Inst (1984) 1.14
Role of metallothionein in carcinogenesis. Toxicol Appl Pharmacol (1994) 1.10
Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer. Prostate (2000) 1.09
P-cadherin expression in breast carcinoma indicates poor survival. Cancer (1999) 1.09
Characterisation of six additional human metallothionein genes. Biochim Biophys Acta (1994) 1.07
Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents. Cancer Res (2001) 1.06
Cell cycle regulation of metallothionein in human colonic cancer cells. Proc Natl Acad Sci U S A (1995) 1.04
Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. J Pathol (2002) 1.03
Significance of metallothionein overexpression in human tumours. Histopathology (1997) 0.97
Differential expression of human metallothionein isoform I mRNA in human proximal tubule cells exposed to metals. Environ Health Perspect (1998) 0.95
Metallothionein expression in human breast cancer. Br J Cancer (1995) 0.95
Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma. Br J Cancer (2000) 0.94
Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. Br J Cancer (2002) 0.93
Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa. J Pathol (1998) 0.93
Human models of breast cancer. Cancer Surv (1993) 0.93
Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther (1997) 0.92
Differential expression of the MT-1E gene in estrogen-receptor-positive and -negative human breast cancer cell lines. Am J Pathol (1998) 0.92
Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer. Br J Cancer (2000) 0.91
Metal transfer as a mechanism for metallothionein-mediated metal detoxification. Cell Mol Biol (Noisy-le-grand) (2000) 0.90
National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res (1993) 0.90
Functional analyses of promoter elements responsible for the differential expression of the human metallothionein (MT)-IG and MT-IF genes. J Biol Chem (1991) 0.90
Immunohistochemical localization of metallothionein in human thyroid tumors. Am J Pathol (1987) 0.90
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. Cancer Res (1994) 0.89
Proliferative potential in nasopharyngeal carcinoma: correlations with metallothionein expression and tissue zinc levels. Carcinogenesis (2000) 0.87
Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype. Surgery (1998) 0.86
Characterization of horse kidney metallothionein isoforms by electrospray MS and reversed-phase HPLC-electrospray MS. Analyst (1998) 0.84
The antioxidant properties of zinc and metallothionein. Neurochem Int (1996) 0.84
Zinc-metallothionein protects from DNA damage induced by radiation better than glutathione and copper- or cadmium-metallothioneins. Toxicol Lett (2003) 0.83
Metallothionein isoform expression by breast cancer cells. Int J Biochem Cell Biol (2000) 0.80
Significance of metallothionein expression in breast myoepithelial cells. Cell Tissue Res (2001) 0.79
Involvement of differential metallothionein expression in free radical sensitivity of RTG-2 and CHSE-214 cells. Free Radic Biol Med (2000) 0.78
Analysis of the metallothionein gene in age-related macular degeneration. Jpn J Ophthalmol (2000) 0.78
Application of real-time reverse transcriptase-polymerase chain reaction in urological oncology. J Urol (2003) 0.77
A monoclonal antibody CIBr17 recognizes a myoepithelium-specific antigen in human mammary gland. Int J Cancer (1986) 0.77
Functional analyses of the human metallothionein-IG gene. In vitro and in vivo studies. J Biol Chem (1995) 0.76
Metallothionein isogene transcription in red blood cell precursors from human cord blood. Eur J Biochem (2001) 0.76
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol (2010) 2.42
Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res (2010) 2.33
Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol (2005) 2.16
Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res (2003) 1.94
Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol (2003) 1.92
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Am J Surg Pathol (2013) 1.83
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol (2007) 1.67
Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology (2014) 1.60
Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene (2003) 1.60
Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res (2008) 1.57
Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clin Cancer Res (2004) 1.46
Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials (2010) 1.44
Atypia in fine needle aspirates of breast lesions. J Clin Pathol (2010) 1.41
Singapore's anatomical future: quo vadis? Anat Sci Educ (2012) 1.39
Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer (2004) 1.37
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy. Breast Cancer Res (2011) 1.37
Supervised learning-based cell image segmentation for p53 immunohistochemistry. IEEE Trans Biomed Eng (2006) 1.36
Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation (2006) 1.34
Breast cell invasive potential relates to the myoepithelial phenotype. Int J Cancer (2003) 1.33
Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis (2002) 1.32
Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer. Clin Cancer Res (2005) 1.30
Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J Clin Invest (2012) 1.29
TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Am J Surg Pathol (2013) 1.28
Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Res (2009) 1.28
Nanoparticle-induced pulmonary toxicity. Exp Biol Med (Maywood) (2010) 1.28
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res (2011) 1.22
Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells. J Biol Chem (2006) 1.20
Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death. Mod Pathol (2005) 1.20
Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod Pathol (2010) 1.19
Induction of autophagy by palmitic acid via protein kinase C-mediated signaling pathway independent of mTOR (mammalian target of rapamycin). J Biol Chem (2012) 1.19
Ureteral endometriosis: clinicopathological and immunohistochemical study of 7 cases. Hum Pathol (2008) 1.19
Breast cancer metastasis. Cancer Genomics Proteomics (2012) 1.18
Blue rubber bleb nevus syndrome: a clinical spectrum with correlation between cutaneous and gastrointestinal manifestations. J Gastroenterol Hepatol (2003) 1.17
Heat shock proteins as novel therapeutic targets in cancer. In Vivo (2008) 1.13
Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. Lung Cancer (2002) 1.13
Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem Pharmacol (2003) 1.12
Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. Cancer Res (2002) 1.12
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat (2011) 1.12
Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol (2011) 1.11
Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder. Clin Cancer Res (2007) 1.09
Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin. Clin Cancer Res (2008) 1.08
Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence. Clin Cancer Res (2013) 1.06
Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression. Breast Cancer Res (2009) 1.06
Breast cancer dormancy can be maintained by small numbers of micrometastases. Cancer Res (2010) 1.06
Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization. Hum Pathol (2008) 1.05
Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol (2006) 1.05
Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer. Int J Oncol (2005) 1.05
Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol (2007) 1.05
TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol (2008) 1.05
Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ. Cancer Res (2010) 1.03
Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion. Breast Cancer Res (2007) 1.03
Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. J Pathol (2002) 1.03
Gold nanoparticles in cancer therapy. Acta Pharmacol Sin (2011) 1.02
Scorpion venoms as a potential source of novel cancer therapeutic compounds. Exp Biol Med (Maywood) (2014) 1.01
Mucinous nonneoplastic cyst of the pancreas: a truly novel pathological entity? World J Gastroenterol (2005) 0.99
p63 is useful in the diagnosis of mammary metaplastic carcinomas. Pathology (2006) 0.98
Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression. Clin Cancer Res (2007) 0.98
Significance of the Y-box proteins in human cancers. J Mol Genet Med (2005) 0.97
Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Mod Pathol (2003) 0.96
Over-expression of metallothionein predicts chemoresistance in breast cancer. J Pathol (2009) 0.96
Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort study. J Clin Pathol (2012) 0.96
Diagnosing breast lesions by fine needle aspiration cytology or core biopsy: which is better? Breast Cancer Res Treat (2010) 0.96
Current studies into the genotoxic effects of nanomaterials. J Nucleic Acids (2010) 0.95
Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters. Mod Pathol (2008) 0.95
Fine needle aspiration cytology of the breast: the nonmalignant categories. Patholog Res Int (2011) 0.95
Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma. Clin Cancer Res (2008) 0.95
Genetic ablation of the alpha 6-integrin subunit in Tie1Cre mice enhances tumour angiogenesis. J Pathol (2010) 0.95
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma. Mod Pathol (2010) 0.94
Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloidlike manner. Am J Physiol Cell Physiol (2002) 0.94
12-Lipoxygenase and the regulation of hypoxia-inducible factor in prostate cancer cells. Exp Cell Res (2010) 0.93
Cell cycle arrest induced by hydrogen peroxide is associated with modulation of oxidative stress related genes in breast cancer cells. Exp Biol Med (Maywood) (2009) 0.93
Intermediate to highly suspicious calcification in breast lesions: a radio-pathologic correlation. Breast Cancer Res Treat (2007) 0.92
Differential reactions of microglia to brain metastasis of lung cancer. Mol Med (2006) 0.92
Increased alpha-B-crystallin expression in mammary metaplastic carcinomas. Histopathology (2011) 0.91
FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations. Mod Pathol (2009) 0.91
A subset of breast cancer predisposes to brain metastasis. Med Mol Morphol (2011) 0.91
Greek anatomist herophilus: the father of anatomy. Anat Cell Biol (2010) 0.90
Y-Box-binding protein-1 is a promising predictive marker of radioresistance and chemoradioresistance in nasopharyngeal cancer. Mod Pathol (2008) 0.90
Keratin expression in breast cancers. Virchows Arch (2012) 0.90
Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasion. J Pathol (2011) 0.89
The induction of epigenetic regulation of PROS1 gene in lung fibroblasts by gold nanoparticles and implications for potential lung injury. Biomaterials (2011) 0.89
Ectopic prostatic tissue: histogenesis and histopathological characteristics. Histopathology (2011) 0.89
Genomic instability of gold nanoparticle treated human lung fibroblast cells. Biomaterials (2011) 0.89
Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma. Chest (2003) 0.88
Clinicopathological significance of metallothioneins in breast cancer. Pathol Oncol Res (2004) 0.88
Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer. Cancer Lett (2005) 0.88
Dietary compounds inhibit proliferation and contraction of keloid and hypertrophic scar-derived fibroblasts in vitro: therapeutic implication for excessive scarring. J Trauma (2003) 0.88
Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signaling. Autophagy (2015) 0.87
Gene expression analysis in human breast cancer associated blood vessels. PLoS One (2012) 0.87
p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Mod Pathol (2005) 0.87